We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+29.22%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$999B
AUM Growth
+$134B
Cap. Flow
-$3.54B
Cap. Flow %
-0.35%
Top 10 Hldgs %
32.24%
Holding
3,356
New
224
Increased
2,237
Reduced
645
Closed
116

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$12.1B
2
AAPL icon
Apple
AAPL
+$11.6B
3
AMZN icon
Amazon
AMZN
+$3.54B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.07B
5
KEYS icon
Keysight
KEYS
+$1.82B

Sector Composition

Rank Sector Weight
1 Technology 37.73%
2 Healthcare 11.3%
3 Financials 10.32%
4 Communication Services 9.66%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSTK icon
2726
Shutterstock
SSTK
$154M
$395K ﹤0.01%
28,247
+4,510
+19% +$71K
AEBI
2727
Aebi Schmidt Holding AG
AEBI
$854M
$393K ﹤0.01%
31,261
+5,294
+20% +$62.5K
PACB icon
2728
Pacific Biosciences
PACB
$504M
$390K ﹤0.01%
231,783
+43,740
+23% +$63.6K
RPC
2729
Ridgepost Capital
RPC
$831M
$390K ﹤0.01%
49,492
+9,728
+24% +$77.5K
CPS icon
2730
Cooper-Standard Automotive
CPS
$403M
$389K ﹤0.01%
14,359
+2,564
+22% +$75.5K
RRBI icon
2731
Red River Bancshares
RRBI
$665M
$389K ﹤0.01%
4,251
+791
+23% +$72.4K
SPCE icon
2732
Virgin Galactic
SPCE
$484M
$389K ﹤0.01%
134,444
+92,104
+218% +$301K
QUAD icon
2733
Quad
QUAD
$485M
$388K ﹤0.01%
45,954
– –
EDIT icon
2734
Editas Medicine
EDIT
$396M
$387K ﹤0.01%
119,429
+10,964
+10% +$32K
IIIV icon
2735
i3 Verticals
IIIV
$268M
$387K ﹤0.01%
18,114
+1,810
+11% +$37.7K
ULCC icon
2736
Frontier Group Holdings
ULCC
$1.43B
$387K ﹤0.01%
48,884
+8,301
+20% +$42.8K
TTAM
2737
Titan America SA
TTAM
$2.55B
$387K ﹤0.01%
20,732
+4,372
+27% +$71.9K
YSS
2738
York Space Systems
YSS
$1.31B
$387K ﹤0.01%
15,698
+3,130
+25% +$97.2K
ATNI icon
2739
ATN International
ATNI
$441M
$386K ﹤0.01%
14,557
+1,134
+8% +$30.8K
ZSQR
2740
Z Squared Inc
ZSQR
$200M
$382K ﹤0.01%
+36,065
New +$442K
TLS icon
2741
Telos
TLS
$302M
$382K ﹤0.01%
82,919
+2,017
+2% +$8.92K
CWCO icon
2742
Consolidated Water Co
CWCO
$446M
$381K ﹤0.01%
12,883
+2,551
+25% +$80K
IBB icon
2743
iShares Biotechnology ETF
IBB
$10.8B
$381K ﹤0.01%
2,000
– –
KRO icon
2744
KRONOS Worldwide
KRO
$950M
$380K ﹤0.01%
59,976
+5,510
+10% +$37.8K
BWB icon
2745
Bridgewater Bancshares
BWB
$579M
$378K ﹤0.01%
17,926
+3,579
+25% +$67.8K
SGMT icon
2746
Sagimet Biosciences
SGMT
$574M
$378K ﹤0.01%
+48,883
New +$332K
HTGC icon
2747
Hercules Capital
HTGC
$3.18B
$377K ﹤0.01%
23,872
-436
-2% -$6.78K
TBI
2748
Trueblue
TBI
$287M
$376K ﹤0.01%
53,898
+6,939
+15% +$38.7K
AQST icon
2749
Aquestive Therapeutics
AQST
$587M
$374K ﹤0.01%
89,848
+17,332
+24% +$72.9K
EMBJ
2750
Embraer S.A. ADS
EMBJ
$14B
$373K ﹤0.01%
5,842
+1,566
+37% +$96.1K

Similar funds

T. Rowe Price Associates's Q2 2026 Portfolio in Review

As of Q2 2026, T. Rowe Price Associates held 3,356 positions worth $999B, up 16% from $865B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q2 2026 filing shows 224 new, 2,237 increased, 645 reduced and 116 closed positions. Its largest new stake was SpaceX: 10,709,016 shares worth $1.83B. The largest sale was Microsoft, an estimated $12.1B.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 34% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q2 2026 buy was SpaceX: 10,709,016 shares worth $1.83B.
  • T. Rowe Price Associates added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.49B increase.
  • T. Rowe Price Associates's biggest Q2 2026 reduction was Microsoft, cutting an estimated $12.1B.
  • T. Rowe Price Associates fully exited Sibanye-Stillwater in Q2 2026, selling an estimated $40.4M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $999B portfolio in Q2 2026.
  • T. Rowe Price Associates opened 224 new positions and closed 116 in Q2 2026.
  • T. Rowe Price Associates's portfolio value rose 16% quarter-over-quarter to $999B.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.